Meridian Bioscience, Inc. operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Meridian Bioscience with three other
companies in this sector in UNITED STATES :
sales of $391.01 million
of which 77%
was Insurance carriers),
of which 51%
was Food Safety), and
Guardant Health Inc
of which 100%
Meridian Bioscience reported sales of $253.67 million
September of 2020.
increase of 26.2%
versus 2019, when the company's sales were $201.01 million.
Sales of Life Sciences saw an increase
that was more than double the company's growth rate: sales were up
106.0% in 2020, from
$64.33 million to $132.54 million.
Not all segments of Meridian Bioscience experienced an increase in sales in 2020:
sales of Diagnostics fell 11.4% to $121.13 million.